|

Placebo for Icalcaprant Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • AbbVie2

Indications

  • Depression2
  • Major Depressive Disorder1
  • Bipolar II Disorder1
  • Bipolar I Disorder1

Dothan, Alabama1 trial

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Harmonex /ID# 277517

Phase 2

Huntsville, Alabama1 trial

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

University of Alabama - Huntsville Regional Medical Campus /ID# 272951

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.